Cited in:


This article has been cited by:

  1. 1
    J. A. Higgins, M. Zainol, K. Brown, G. D. D. Jones, Anthocyans as tertiary chemopreventive agents in bladder cancer: anti-oxidant mechanisms and interaction with mitomycin C, Mutagenesis, 2014, 29, 4, 227


  2. 2
    Frank Emmert-Streib, Funso Abogunrin, Ricardo de Matos Simoes, Brian Duggan, Mark W Ruddock, Cherith N Reid, Owen Roddy, Lisa White, Hugh F O'Kane, Declan O'Rourke, Neil H Anderson, Thiagarajan Nambirajan, Kate E Williamson, Collectives of diagnostic biomarkers identify high-risk subpopulations of hematuria patients: exploiting heterogeneity in large-scale biomarker data, BMC Medicine, 2013, 11, 1, 12


  3. 3
    Sue Osborne, Madhusudan Koya, One stop nurse-led macroscopic haematuria clinic: waiting times and patient satisfaction, International Journal of Urological Nursing, 2013, 7, 3
  4. 4
    Funso Abogunrin, Hugh F. O'Kane, Mark W. Ruddock, Michael Stevenson, Cherith N. Reid, Joe M. O'Sullivan, Neil H. Anderson, Declan O'Rourke, Brian Duggan, John V. Lamont, Ruth E. Boyd, Peter Hamilton, Thiagarajan Nambirajan, Kate E. Williamson, The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria, Cancer, 2012, 118, 10
  5. 5
    Richard T. Bryan, Michael A. Wallace, IS IT TIME TO RE-DESIGN THE HAEMATURIA CLINIC?, BJU International, 2010, 105, 10